Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutral metallated and meso-substituted porphyrins as antimicrobial agents against gram-positive pathogens.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011
Same author

Impact of medical interventions on quality of life in cardiovascular disease: a consensus viewpoint.

The Canadian journal of cardiology·1997
Same author

Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction.

The New England journal of medicine·1996
Same author

Does it matter how coronary projections are combined to assess restenosis following PTCA?

International journal of cardiac imaging·1995
Same author

Resection of hepatic and pulmonary metastases from colorectal cancer.

Surgical oncology·1992
Same author

An enzyme-linked immunosorbent assay for enumeration of Pneumocystis carinii in vitro and in vivo.

Journal of clinical microbiology·1992

Related Experiment Video

Updated: Jul 21, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Influenza vaccination in a training establishment

J B Gill, P K Fraser, J W Smith

    Journal of the Royal Naval Medical Service
    |January 1, 1973
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection
    07:45

    Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection

    Published on: September 19, 2025

    Related Experiment Videos

    Last Updated: Jul 21, 2026

    Expression and Purification of Virus-like Particles for Vaccination
    06:17

    Expression and Purification of Virus-like Particles for Vaccination

    Published on: June 2, 2016

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection
    07:45

    Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection

    Published on: September 19, 2025